AI Insight: Innoviva’s current price at $21.28 is significantly below the high-confidence fair value of $47.46, indicating substantial upside potential with low downside risk per Monte Carlo analysis. Robust financial health scores (5/5) support operational stability. However, valuation dispersion and a 47.14% coefficient of variation suggest notable volatility risk.